Sensitivity of BCG to modern antibiotics

European Urology

Volumn 37, Issue SUPPL. 1, 2000, Pages 21-25

  Durek, C ^a   Rusch Gerdes S ^b   Jocham, D ^a   Bohle A ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Antibiotics cycloserine; Bacillus Calmette Guerin; BCG; Bladder cancer; Immunotherapy

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; BCG VACCINE; BETA LACTAM; CLARITHROMYCIN; CYCLOSERINE; DOXYCYCLINE; GENTAMICIN; KANAMYCIN; MACROLIDE; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; BACILLUS; BACTERIUM CULTURE; BLADDER CANCER; CANCER RECURRENCE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG SENSITIVITY; DRUG URINE LEVEL; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEPSIS; SIDE EFFECT;

EID: 0033979436     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052378     Document Type: Conference Paper

References (24)